Determination That SULFADIAZINE (Sulfadiazine) Tablet, 500 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that SULFADIAZINE (sulfadiazine) tab...
Publisher
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- September 29, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA or Agency) has determined that SULFADIAZINE (sulfadiazine) tab...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Evidence: Tier 1 路 Regulatory source
Related coverage
More related coverage
Weekly all-cause mortality surveillance: week ending 11 April 2027 (week 16)
How the actual number of deaths in England compare with expected numbers for each week.
Weekly all-cause mortality surveillance: week ending 4 April 2027 (week 15)
How the actual number of deaths in England compare with expected numbers for each week.
Adult social care client level data, England: quarterly update
Official statistics in development on insights from client level data from local authorities, includ...
Adult social care client level data, England: quarterly update to March 2026
Official statistics in development on insights from client level data from local authorities, includ...